Cart
sales@molnova.com
Parimifasor
CAS No. 1796641-10-5
Parimifasor( LYC-30937-EC | LYC30937 )
Catalog No. M12714 CAS No. 1796641-10-5
Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 2MG | 54 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 407 | In Stock |
|
| 100MG | 602 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameParimifasor
-
NoteResearch use only, not for human use.
-
Brief DescriptionParimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
-
DescriptionParimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).Psoriasis Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsLYC-30937-EC | LYC30937
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
IndicationPsoriasis
Chemical Information
-
CAS Number1796641-10-5
-
Formula Weight460.214
-
Molecular FormulaC18H11Cl2F4N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥150 mg/mL （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(/N=C(NC1=CC(F)=CC(Cl)=C1)\NC2=NNC(C(F)(F)F)=C2)C3=CC=CC(Cl)=C3
-
Chemical Name3-chloro-N-[(3-chloro-5-fluoroanilino){[5-(trifluoromethyl)-1H-pyrazol-3-yl]amino}methylidene]benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Transdermal Peptide ...
Transdermal Peptide TFA (TD 1 Peptide TFA) is an 11-amino acid polypeptide that binds to Na+/K+ -atpase beta-subunit (ATP1B1) and interacts with the C terminal of ATP1B1.Transdermal Peptide TFA can enhance the transmission of some large molecules in the skin.
-
Phenyl-ac-Gly-OH
Phenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. The presence of phenylacetylglycine in urine has been confirmed for dogs rats and mice. However the presence of this compound in human urine is controversial. GC-MS studies have not found this compound while NMR studies claimed to have identified it.
-
δ-MSH
δ-MSH
